Categoria: Articoli in lingua originale

Type 1 Diabetes Risk Lower in Infants with Rotavirus Vaccination

Vaccines safely and effectively prevent the spread of infectious disease and some even prevent cancer. Now, a somewhat surprising benefit of vaccination is being suggested by a large epidemiological study that revealed that getting fully vaccinated against rotavirus in the first months of life is associated with a lower risk

Continua a leggere

Systemic lupus erythematosus (SLE): sustained clinical benefit and reduction in severe flares with Stelara® (ustekinumab) #EULAR2019

The Janssen Pharmaceutical Companies of Johnson & Johnson presented this week results of two analyses from a Phase 2 study of Stelara®*(ustekinumab) in systemic lupus erythematosus (SLE). The studies highlight not only the sustained clinical benefit of ustekinumab – an anti-interleukin (IL) IL-12/23 p40 neutralising monoclonal antibody – on SLE

Continua a leggere

Rates of Diagnosed Diabetes in the U.S. Seem to Be Falling

The incidence of diabetes among U.S. adults shows apparent signs of retreat, according to a study in BMJ Open Diabetes Research & Care. Using nationally representative data, CDC scientists traced incidence and prevalence trends between 1980 and 2017. The diabetes prevalence rate was stable between 1980 and 1990, at roughly 3%.

Continua a leggere

Storage Conditions of Insulin in Domestic Refrigerators and When Carried by Patients: Often Outside Recommended Temperature Range

Abstract Objective: Not much is known about how people with diabetes store their insulin. Objective of our evaluation was to analyze at which temperature insulin is stored in domestic refrigerators and when opened/carried as a spare, and if these temperatures meet the manufacturers’ recommendations. Methods: People with diabetes (n = 338;

Continua a leggere

Only 20% With Type 1 Diabetes Are Meeting HbA1c Goals

Only about one in five people with type 1 diabetes in the United States is achieving optimal glycemic control despite increased use of technologies such as insulin pumps and continuous glucose monitors (CGMs), new data show. The findings, from the T1D Exchange registry, were recently published online in Diabetes Technology & Therapeutics by Nicole

Continua a leggere
Skip to content